Mr. Dan Foley reports
CURALEAF ANNOUNCES OPENING OF NEW ARIZONA DISPENSARY
Curaleaf Holdings Inc. has opened its seventh dispensary in Arizona at 217 N 83rd Ave. in the Phoenix metro area. Curaleaf Pavilions is a newly developed, flagship dispensary with close access to the I-10 Freeway. The dispensary is in the immediate vicinity of the nationally recognized Ak-Chin Pavilion, a popular outdoor amphitheater and concert stadium hosting nearly 40 events a year.
"Maricopa is the fastest-growing county in the country," said Joe Lusardi, president and chief executive officer of Curaleaf. "By opening the seventh Curaleaf dispensary in Arizona, we will be able to provide this expanding population with access to our high-quality cannabis products and exceptional customer service."
To celebrate, Curaleaf Pavilions will host a grand opening party on Friday, Oct. 4. The event will feature product specials, including BOGO (buy-one-get-one) discounts on select products, giveaways and prizes.
Earlier this year, Curaleaf agreed to acquire Phytotherapeutics Management Services LLC. The licence associated with that dispensary was applied to Curaleaf Pavilions.
The opening of Curaleaf Pavilions follows the recently completed acquisition of Glendale Greenhouse and represents the company's third acquisition in the state of Arizona over the past four months, giving Curaleaf the second largest retail footprint in the state. Curaleaf's successful expansion in Arizona is emblematic of its aggressive expansion plans across the United States, including the completed acquisition of Eureka in California and the pending acquisitions of Acres in Nevada, Select and Grassroots.
Curaleaf Pavilions is open daily from 8 a.m. to 10 p.m. Free ample parking is available. In an effort to improve accessibility to medical cannabis, Curaleaf offers a wide range of standing discounts as well as on-line ordering through its website.
About Curaleaf Holdings Inc.
Curaleaf Holdings is the leading vertically integrated multistate cannabis operator in the United States. It is a high-growth cannabis company with a national brand known for quality, trust and reliability. The company is positioned in highly populated, limited licence states and currently operates in 12 states with 49 dispensaries, 14 cultivation sites and 13 processing sites. Curaleaf has the executive expertise and research and development capabilities to provide leading service, selection and accessibility across the medical and adult-use markets, as well as in the cannabidiol category through its Curaleaf Hemp brand.
We seek Safe Harbor.
© 2020 Canjex Publishing Ltd. All rights reserved.